Test results

With the help of the Predemtec DX Software integrated into the ELISA analyzer, the patients’ risk profiles can be generated based on the individual results from the concentration of the six biomarkers and a specific algorithm. This profile shows whether an increased Alzheimer’s risk, or the disease itself, is present and which therapeutic interventions, if any, are advisable.